generic-drugs
Generic Medicine Pharma Products

The Pros and Cons of Using Generic Drugs

According to the Food and Drug Administration (FDA), generic drugs are biologically equivalent to brand name drugs in dosage form, strength, safety, route of administration, quality, performance characteristics, and intended use. Basically, a generic drug is a copycat of a brand name medication (made after the patent from the brand name has ended). They’re likewise typically a more affordable solution.

Generic drugs seem to be getting more and more famous when it comes to significant brand name drugs, including many medications related to heart health like blood pressure and statins medication.

In fact, a record 86% of prescriptions dispensed in 2017 were for generic drugs versus brand-name drugs as per the IQVIA, one of the world’s largest contract research organizations.

Yet, exactly how safe is generic drugs when it comes to staying heart healthy? Let’s take a look at some of the pros and cons of generic medication below.

Pros:

    • Cheaper prices. The main reason so many people purchase generic drugs is that they are more cost-effective than brand name drugs. Brand name drugs require research and testing that take a lot of money and time, however, generic drugs only need to copy what as of now exists, saving them the cost and permitting the price to stay low.
    • Biologically speaking, generic drugs should satisfy precise guidelines so that the same amount of active ingredient is conveyed to the body simultaneously, and utilized by the body, in the same way as the brand name product.
    • FDA approved. The FDA sets severe guidelines and performs research on generic drugs to ensure that they are bioequivalent to the brand name.
    • Heart Healthy. As indicated by a recent study, generic heart medications show the same medical outcomes as brand name medications.

Cons:

    • Contamination. Generic drugs are frequently produced in factories in countries like China, India, or other areas with cheap labor and overhead. The conditions at these manufacturing plants have sometimes contaminated drugs, leading to recalls in the United States. To be reasonable, however, there have been a handful of situations where even US-based brand name drugs had similar issues although probably not nearly as frequently.
    • As per the report by the Government Accountability Office, these foreign factories sometimes escape rigorous FDA inspections, dodge documentation of their practices, and don’t get follow-up monitoring even when genuine manufacturing or drug-handling problems have been recognized. Generally, only one manufacturer produces a brand name drug whereas a couple of manufacturers can produce a generic drug. While the FDA insists on the bioequivalence of the active medication, there sometimes can be unpretentious differences in the delivery system of the drug or non-active “fillers” for the drug. These distinctions rarely result in any clinically significant issue for the patient despite the fact that in rare cases a patient might have a sensitivity or intolerance to an alternate filler or delivery system.
    • Mixing up the pills. As brand medications ordinarily have a consistent “branded” look to them that patients can get familiar and comfortable with, generics frequently don’t look as familiar or it isn’t as obvious what each pill seems to be. Moreover, when a prescription is refilled, if the drug is made by a different generic manufacturer and has a different appearance, this can prompt drug confusion and blunders or even patients not taking the pills they are recommended.
    • Doctors remain divided. Many medical experts are still divided on the utilization of generic drugs for heart disease, leaving some lingering doubt in this area. Some particular medications including thyroid supplements and blood thinners have had evidence of genuine clinically meaningful issues when switching between brand and generic or between different generics.

More and more frequently patients discover their brand name prescription medication won’t be covered by their insurance plan or their co-pay is higher. Regularly, the insurer will offer a generic version at a co-pay that is less. Luckily, at this point, the vast majority of cardiac medications are accessible in the generic form with commonly no obvious problems for the vast majority of patients.

When patients start on a new medication that is easily available from a generic drug manufacturer, it is usually recommended starting with the generic form if there is no scientific agreement that the brand name version is any better. While usually, the patient will likewise save money directly, we all benefit from the total reduction in health care costs. If a patient has been on a brand medication and can save cash by adopting the generic formulation or even a more affordable brand of the same drug class, it typically should be possible without any ill effects but we believe it ultimately ought to be the patient’s choice after consulting with their physicians. Many patients prefer not to “rock the boat” and not make the switch. While that is not unreasonable, one needs to weigh whether it is worth the additional expense.

If you have any questions or concerns about taking a generic versus a brand-name medication, reach out to us at JoinHub Pharma.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

 

generic-drugs
Generic Medicine Pharma Products

The Mysteries Between The Branded Drugs Vs The Generic Drugs

Branded drugs are manufactured by an organization and are always sold under a brand name. Patents for such kinds of drugs can be obtained by including different inactive components to the drug, for example, flavoring and coloring agents.

Generic drugs are similar to branded drugs, yet they contain only the active components that are important to be included for the drug to be effective. Generic drugs don’t contain unnecessary inactive elements as branded drugs do. Generic drugs can be sold in the market once the branded drugs’ patents have lapsed, which is typically around 20 twenty years from the date of patent approval.

The Indian Pharma Market

India is perhaps the largest manufacturer of generic drugs globally. The Indian pharmaceutical sector industry supplies more than half of the global demand for different kinds of vaccinations. India holds a considerable position in the global pharmaceutical market as a supplier. The nation also consists of a large pool of scientists and engineers with the potential required to level the pharma industry up to a higher standard.

The Indian pharmaceutical market is foreseen to obtain the 9th position in the global market by 2023, thanks to different top-tier pharmaceutical companies that produce branded drugs that are sold highly in the market compared to generic drugs. Examples of some popular pharmaceutical companies include:

  • Sun Pharmaceutical Industries Limited
  • JoinHub Pharma
  • Aurobindo Pharma Limited
  • Lupin Limited
  • Cipla Limited
  • Reddy’s Laboratories
  • Cadila Healthcare Limited
  • Intas Pharmaceuticals Limited

 

The Role of the FDA

The Food and Drug Administration department is actively taking part in the promotion of generic drugs worldwide, as it increases the availability of medicine at cheap prices.

Before launching a generic medicine in the market, the medicine must be approved by the FDA, who meticulously reviews the product and additionally guarantees that the drug meets certain standards applied for the approval of a branded drug. The department finds various steps to guarantee the safety and quality of drugs before and after it is launched in the market.

Even after the approval of any generic drug, the FDA keeps on observing the medicine’s level of safety to make sure that the products being sold to consumers are effective, safe, and of high quality. Thus, the FDA plays a significant part in offering quality medicine to those who require it, anywhere around the globe.

 

Difference between branded drugs and generic drugs

  • Branded drugs and generic drugs have similar active ingredients that are needed for the drug to be effective in nullifying the health condition. Branded and generic drugs are likewise similar when it comes to intake dosages and their strengths, with virtually no difference in their outcomes.
  • Branded drugs differ a lot from generic drugs in terms of size, shape, and color – this is generally done to facilitate patent approval, which needs a significant amount of distinction from existing drugs with comparative chemical compositions.
  • They are likewise discovered to have different inactive ingredients – branded drugs are heavy in content unrelated to the working of the drug, such as coloring and flavoring agents, on the other hand, generic drugs don’t include the utilization of gustatory and visual stimulation.
  • They are different in shapes, sizes, and colors.
  • They have different inactive ingredients. Most often only branded drugs have inactive components.
  • Generic drugs are more affordable than branded drugs.
  • Branded drugs are sold under a company’s name whereas generic drugs do not.

 

Clarifications:

Generic medication typically costs about 80% to 85% less than branded drugs. Generic drugs are less expensive because the manufacturer doesn’t have to develop and market a new drug, nor go through the troubles of researching, licensing, and getting it approved. It does not contain inactive components that are added to make them smell, look, and taste better, clearly leading to less expensive production costs.

  • Are generic drugs safe?

Indeed, Generic drugs are totally safe, as they are highly regulated and experience a rigorous review process before they are approved in the market. The Food and Drug Administration (FDA) tests the generic drugs to ensure that the drug is safe to be utilized by those afflicted with the disease being battled. The FDA only approves drugs if they meet all the guidelines for safe usage. After drug approval, the FDA will frequently inspect the manufacturing plant where the drug is manufactured and will monitor the drug for any safety concerns.

  • Why do branded drugs and generic drugs look different?

The shape, size, and color of the generic drugs and the branded drugs make them look unique.

 

Conclusion

It is apparent that Indian generic drug companies are growing at a fast pace. India is the biggest manufacturer of generic drugs in the world and thereby it helps to strengthen India’s burgeoning economy. A survey submitted by Global Business Report has stated that India’s pharma exports have increased by 11% in 2019, which is quite satisfactory. However, the popularity and demand for branded drugs in the market overpowers the presence of generic drugs.

Expensive branded medicines available in the market cannot be affordable by everyone. So, the Drug Price Control Order (DPCO) has decreased the price of some branded drugs. Regardless of this price reduction, a couple of branded drugs are still selling at high rates. Thus, the best alternative to these expensive branded drugs is generic drugs. The government must promote and advertise generic drugs to make them available to everyone. People should also start adopting generic medicines. Giving more into generic drugs will help them establish a strong presence in the market, which when combined with their cheap prices, will be the traction they require in the limit of pharmaceutical economies worldwide.

Get in touch with our experts at JoinHub Pharma today to know the pricing model of generic drugs.

Contact us for more information:
Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

generic-drug
Pharma Products Pharmaceutical Manufacturing

Top 5 Generic Drug Makers in India

The demand for generic drugs is increasing worldwide and pharmaceutical companies are realizing the great potential this opportunity affords. Efficient and Cheap drugs are always needed, making this a growing business sector for drugmakers. The global market for generic drugs is projected to rise at a compound annual growth rate (CAGR) of 8.7 percent; meaning that, in the forecast period 2016 to 2021, the global market will increase from $352 billion to $533 billion.1
In this article, the top five generic drug makers are listed by total revenue, measured in the financial year (FY) 2018. Counting down, they are as follows

JoinHub Pharma
JoinHub Pharma is an award-winning Pharmaceutical Company in India. We hold a reputed name with regards to branded medicines and generic medicines. Our company is certified by the highest authority like WHO, FDA, ISO 9001:2008, GMP, etc. We are a top pharma manufacturer known for our top of the line quality pharma products and services. Without a doubt, we are considered to be one of the best generic medicine manufacturers in India. In fact, 85% of our revenue is generated by way of exporting to MIDDLE EAST, CIS, and AFRICA production facilities. We are popular for our widest list of medicines which contains more than 1000+ pharma products.

The range of products we manufacture are:

● Tablet, Capsules and soft gel capsules, Injection, oral liquid, external
● preparations cream, ointments, suspensions, eye ear nasal drops in different
● therapeutic expertise CNS,
● Anticonvulsant, anti-diabetic, anticancer, antibiotics, antiviral, antibacterial,
● immunosuppressants,
● hormone, nutraceutical, derma care, probiotic, prebiotic, cough,
● expectorant, NSAIDs, nephrology and urology, oral contraceptives, gynecology,
● oral health care and many more

Every manufacturing is done in our company-owned GMP-WHO certified units. What makes us best to associate with and become our client?

Here are the points for consideration:

● Latest Packaging Technology like ALU-ALU is utilized.
● Manufacturing Agreement is kept transparent through clarified terms and
● conditions. It likewise incorporates Intellectual property Rights,
● We have a reputation for updating with long term relations.
● Widest range of 1000+ pharma items
● Skilled R&D team with completely furnished automated laboratory,
● Manufacturing happens in excise duty-free zones which make the business deal moderate.
● Approved pharma products from Food & Dry Administration (FDA) for every medicine
● Approvals from DCGI and FSSAI for all products
● Units and plants certified by well-known associations including Good
● Manufacturing Products (GMP) and the World Health Organization (WHO)
● Secrecy is maintained about the generic drug product formulation with everything being equal.
● Abbreviated New Drug Application (ANDA) approval to advertise a generic drug product has been taken care of by the organization itself.

Lupin Pharmaceuticals
This pharmaceutical company is based in Mumbai, India. Lupin Pharmaceuticals is a subsidiary of Lupin Limited and one of the top five pharmaceutical companies in the country, making it a key player in the industry. The company was founded in 1968 and while its main focus is generic drugs, it also manufactures branded medications and active pharmaceutical ingredients (API).

Sun Pharmaceuticals
Sun Pharmaceuticals, also headquartered in Mumbai and has over 2,000 marketed products. According to Sun Pharmaceuticals, they have built a portfolio of about 10 specialty products, five of which are already on the market. They expect that this side of their business will be a key driver in the coming financial year.5 In addition to being a leading generic drug maker, the company also provides a range of APIs. They invest heavily in R&D, using around 7-8 percent of their annual revenues to improve this side of their business. Established in 1983, Sun Pharma sold items across India before expanding globally in 1996.

Sandoz
Sandoz is a generic and biosimilar producer division of the Novartis Group. Headquartered in Munich, Germany,10 the company merged with Ciba-Geigy in 1996 to form Novartis. According to the company, a planned transformation for Sandoz through Novartis is expected to enable them to compete effectively in a more challenging environment by increasing their share of higher-margin differentiated products. The retail generics franchise amounted to 80% of the company’s total business, followed by biopharmaceuticals (15%) and anti-infectious (5%). Sandoz also offers a variety of drug delivery mechanisms.

Teva Pharmaceutical Industries Ltd
Based in Jerusalem, Israel, Teva is the world’s leading generic drug maker; yet it’s also active in ventures that include APIs. Teva manufactured nearly 120 billion tablets with one out of nine generic prescriptions in the US containing the organization’s products. Teva says that it has a unique understanding of local markets. Founded in 1901, Teva began as a small wholesale drug business distributing imported medications. In the 1980s, it then expanded internationally and entered the US market.18 With a specialty R&D program, the company says it has a “robust pipeline” of high-value medications

Conclusion
Generic drug makers have vast potential in the market and, due to the high demand for generics, significant profits exist to return investments. Opportunities for these companies provide the potential for even greater growth in the future, with the market set to increase soon.

Call : +91 9979382527
Mail us at [email protected]
Website: https://joinhubpharma.com

CALL ME BACK